Home/Filings/4/0000914190-25-000040
4//SEC Filing

Spandow Oliver J. 4

Accession 0000914190-25-000040

CIK 0001196298other

Filed

Nov 12, 7:00 PM ET

Accepted

Nov 13, 4:59 PM ET

Size

14.5 KB

Accession

0000914190-25-000040

Insider Transaction Report

Form 4
Period: 2025-11-10
Transactions
  • Award

    Common Stock

    2025-11-10+8,036122,881 total
Holdings
  • Stock Option (Right to Buy)

    Exercise: $5.85Exp: 2028-12-19Common Stock (5,161 underlying)
    5,161
  • Stock Option (Right to Buy)

    Exercise: $1.47Exp: 2035-01-01Common Stock (7,050 underlying)
    7,050
  • Stock Option (Right to Buy)

    Exercise: $8.06Exp: 2031-01-06Common Stock (6,850 underlying)
    6,850
  • Stock Option (Right to Buy)

    Exercise: $1.07Exp: 2033-01-05Common Stock (7,080 underlying)
    7,080
  • Stock Option (Right to Buy)

    Exercise: $2.14Exp: 2034-05-14Common Stock (7,323 underlying)
    7,323
  • Stock Option (Right to Buy)

    Exercise: $5.58Exp: 2028-08-10Common Stock (9,466 underlying)
    9,466
  • Stock Option (Right to Buy)

    Exercise: $8.57Exp: 2029-12-16Common Stock (5,568 underlying)
    5,568
  • Stock Option (Right to Buy)

    Exercise: $6.82Exp: 2031-12-14Common Stock (7,062 underlying)
    7,062
Footnotes (3)
  • [F1]Fully exercisable.
  • [F2]This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.
  • [F3]This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.

Issuer

NEPHROS INC

CIK 0001196298

Entity typeother

Related Parties

1
  • filerCIK 0001749836

Filing Metadata

Form type
4
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:59 PM ET
Size
14.5 KB